academic article

• Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model..  American journal of hematology.  86:155-162. 2011
• A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia..  Infection and immunity.  78:453-460. 2010
• Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10..  Clinical immunology (Orlando, Fla.).  126:211-221. 2008
• Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production..  The Journal of infectious diseases.  198:1219-1226. 2008
• Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria..  The American journal of tropical medicine and hygiene.  76:1033-1036. 2007
• Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia..  Infection and immunity.  75:201-210. 2007
• Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia..  Infection and immunity.  74:5249-5260. 2006
• Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children..  The American journal of tropical medicine and hygiene.  74:573-577. 2006
• Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria..  Clinical immunology (Orlando, Fla.).  119:219-225. 2006
• Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria..  AIDS (London, England).  20:275-280. 2006
• Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area..  The American journal of tropical medicine and hygiene.  74:376-385. 2006
• Suppression of RANTES in children with Plasmodium falciparum malaria..  Haematologica.  91:1396-1399. 2006
• Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia..  The Journal of infectious diseases.  193:1384-1393. 2006
• Differential regulation of beta-chemokines in children with Plasmodium falciparum malaria..  Infection and immunity.  73:4190-4197. 2005
• Stage-specific effects of Plasmodium falciparum-derived hemozoin on blood mononuclear cell TNF-alpha regulation and viral replication..  AIDS (London, England).  19:1771-1780. 2005
• Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells..  Infection and immunity.  72:4868-4873. 2004
• Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism..  Molecular medicine (Cambridge, Mass.).  10:45-54.
• Suppression of a novel hematopoietic mediator in children with severe malarial anemia..  Infection and immunity.  77:3864-3871.